Anna Tostevin
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 16
- HIV/AIDS Research and Interventions 4
- SARS-CoV-2 detection and testing 1
- Virology 6
- HIV Research and Treatment 6
- Co-authors
- David Dunn (16 shared papers)Valérie Delpech (5 shared papers)Anton Louis Pozniak (7 shared papers)Caroline Anne Sabin (8 shared papers)Alison E Brown (4 shared papers)Ellen White (4 shared papers)Deenan Pillay (4 shared papers)Stéphane Hué (2 shared papers)
- Journals
- HIV Medicine (4 papers)Journal of Antimicrobial Chemotherapy (3 papers)The Journal of Infectious Diseases (2 papers)Clinical Infectious Diseases (2 papers)Antiviral Therapy (2 papers)
- Partner nations
- United KingdomSouth AfricaDenmark
In The Last Decade
Anna Tostevin
23 papers receiving 540 citations
Peers
Comparison fields: 5 of 50
- Virology 230
- Infectious Diseases 425
- Emergency Medicine 21
- Epidemiology 63
- Speech and Hearing 10
Countries citing papers authored by Anna Tostevin
This map shows the geographic impact of Anna Tostevin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Tostevin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Tostevin more than expected).
Fields of papers citing papers by Anna Tostevin
This network shows the impact of papers produced by Anna Tostevin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Tostevin. The network helps show where Anna Tostevin may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Tostevin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 219 | |
| 2 | 2016 | 63 | |
| 3 | 2017 | 37 | |
| 4 | 2018 | 34 | |
| 5 | 2017 | 24 | |
| 6 | 2018 | 23 | |
| 7 | 2016 | 21 | |
| 8 | 2021 | 19 | |
| 9 | 2020 | 17 | |
| 10 | 2017 | 12 | |
| 11 | 2016 | 12 | |
| 12 | 2019 | 10 | |
| 13 | 2019 | 8 | |
| 14 | 2018 | 8 | |
| 15 | 2018 | 7 | |
| 16 | 2023 | 7 | |
| 17 | 2020 | 4 | |
| 18 | 2017 | 4 | |
| 19 | 2018 | 4 | |
| 20 | 2015 | 4 |
About Anna Tostevin
Anna Tostevin is a scholar working on Infectious Diseases, Virology, Hepatology, Emergency Medicine and Hematology, having authored 23 papers that have together received 546 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (16 papers), HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (4 papers), HIV-related health complications and treatments (1 paper), HIV, Drug Use, Sexual Risk (1 paper), SARS-CoV-2 detection and testing (1 paper), Blood groups and transfusion (1 paper) and Hepatitis C virus research (1 paper). The work is most often cited by research in Virology (230 citations), Infectious Diseases (425 citations), Emergency Medicine (21 citations), Epidemiology (63 citations) and Speech and Hearing (10 citations). Anna Tostevin has collaborated with scholars based in United Kingdom, South Africa and Denmark. Frequent co-authors include David Dunn, Valérie Delpech, Anton Louis Pozniak, Caroline Anne Sabin, Alison E Brown, Ellen White, Deenan Pillay, Stéphane Hué, Oliver Ratmann and Erik Volz. Their work appears in journals such as HIV Medicine, Journal of Antimicrobial Chemotherapy, The Journal of Infectious Diseases, Clinical Infectious Diseases and Antiviral Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.